This study is being conducted to test the effects (both good and bad) of an experimental in-situ (in-place), personalized cancer vaccine protocol that combines the experimental drug, AlloStim™, with a minimally invasive tumor cryoablation procedure.  The protocol  tests a new theory on how to educate the immune system to recognize the danger that cancer poses to the body and stimulate an active immune response against the cancer cells whereever they reside in the body.  Study doctors will determine if the vaccine protocol causes any side-effects, will analyze your immune response to the vaccine protocol, as well as determine if the vaccination had any effect on controlling or reducing the amount of tumor in your body.